Cargando…
Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection()
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423841/ https://www.ncbi.nlm.nih.gov/pubmed/34514160 http://dx.doi.org/10.1016/j.medcle.2021.03.010 |
| _version_ | 1783749553888952320 |
|---|---|
| author | Doello, Kevin Amezcua, Víctor |
| author_facet | Doello, Kevin Amezcua, Víctor |
| author_sort | Doello, Kevin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8423841 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84238412021-09-08 Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection() Doello, Kevin Amezcua, Víctor Med Clin (Engl Ed) Scientific Letter Elsevier España, S.L.U. 2021-09-24 2021-09-08 /pmc/articles/PMC8423841/ /pubmed/34514160 http://dx.doi.org/10.1016/j.medcle.2021.03.010 Text en © 2021 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Scientific Letter Doello, Kevin Amezcua, Víctor Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection() |
| title | Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection() |
| title_full | Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection() |
| title_fullStr | Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection() |
| title_full_unstemmed | Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection() |
| title_short | Effect of adding bemiparin and cefepime to routine treatment in cancer patients with SARS-CoV-2 infection() |
| title_sort | effect of adding bemiparin and cefepime to routine treatment in cancer patients with sars-cov-2 infection() |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423841/ https://www.ncbi.nlm.nih.gov/pubmed/34514160 http://dx.doi.org/10.1016/j.medcle.2021.03.010 |
| work_keys_str_mv | AT doellokevin effectofaddingbemiparinandcefepimetoroutinetreatmentincancerpatientswithsarscov2infection AT amezcuavictor effectofaddingbemiparinandcefepimetoroutinetreatmentincancerpatientswithsarscov2infection |